Phase 3 IBS Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Ebastine Versus Mebeverine in IBS Patients
IBS - Irritable Bowel SyndromeIBS
Guy Boeckxstaens200 enrolled5 locationsNCT05815602
Recruiting
Phase 3
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years
Irritable Bowel Syndrome With Constipation (IBS-C)
Ardelyx180 enrolled41 locationsNCT05643534
Completed
Phase 2Phase 3
A double-blind, randomised, placebo-controlled clinical trial to investigate the efficacy and safety of Cannabidiol (CBD) oral oil versus placebo, for the management of abdominal pain in patients with irritable bowel syndrome (IBS)
Irritable Bowel Syndrome (IBS)
Schneider Von Gunn Pharmaceuticals200 enrolled1 locationACTRN12622001179729
Recruiting
Phase 3
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome
IBS - Irritable Bowel Syndrome
Tanta University60 enrolled1 locationNCT04217733
Completed
Phase 3
A Randomised, Double-blinded, Placebo-controlled Study of Kivia (Trademark) 575mg Zyactinase (Registered Trademark) Capsule for the Improvement of Digestive Health Parameters in Subjects with Irritable Bowel Syndrome with Constipation Symptoms
Constipation dominant Irritable Bowel Syndrome (IBS-C)
Vital Food Processors Ltd180 enrolled10 locationsACTRN12613001222730